TileBio
1 known investors
TileBio develops self-supervised AI foundation models for digital pathology, applied to cancer diagnosis, prognosis, biomarker discovery, and drug development. It serves clinicians, diagnostics, and pharmaceutical research by analysing pathology imaging and sequencing data.
Founders & leadership
CW
Christopher WalshCo-Founder / CEO & CTO
KY
Ke YuanCo-Founder / CSO
DC
David ChangCo-Founder / CMO
JL
John Le QuesneCo-Founder / CMO